论文部分内容阅读
目的对通心络胶囊在冠状动脉粥样硬化性心脏病治疗中的临床效果进行分析和总结。方法 66例冠状动脉粥样硬化性心脏病患者,随机分成为研究组和对照组,每组33例。对照组给予阿托伐汀治疗,研究组在对照组基础上给予通心络胶囊治疗,比较两组的治疗效果。结果研究组总有效率为90.91%,明显优于对照组的69.70%(P<0.05)。研究组的血脂改善情况明显优于对照组(P<0.05或0.01)。研究组不良反应少于对照组(P<0.05)。结论采用通心络胶囊治疗冠状动脉粥样硬化性心脏病,能够有效缓解患者的临床症状,改善患者心功能,疗效确切,值得推广。
Objective To analyze and summarize the clinical effect of Tongxinluo capsule in the treatment of coronary atherosclerotic heart disease. Methods 66 patients with coronary atherosclerotic heart disease were randomly divided into study group and control group, with 33 cases in each group. The control group was treated with atorvastatin. The study group was given Tongxinluo capsule on the basis of the control group, and the treatment effect was compared between the two groups. Results The total effective rate was 90.91% in the study group, which was significantly better than 69.70% in the control group (P <0.05). The study group’s blood lipid improvement was significantly better than the control group (P <0.05 or 0.01). Adverse reactions in the study group were less than those in the control group (P <0.05). Conclusion Tongxinluo capsule treatment of coronary atherosclerotic heart disease, can effectively alleviate the clinical symptoms of patients and improve cardiac function, curative effect is exact, it is worth promoting.